STOCK TITAN
  1. Home
  2. Sec-filings
  3. GERN
  4. [Form 4] GERON CORP Insider Trading Activity

Geron (GERN) awards director Susan Molineaux 220,000 stock options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Geron Corp director Susan Molineaux received a compensation grant of stock options covering 220,000 shares of common stock at an exercise price of $1.26 per share. The option vests in full on the earlier of the company’s next annual stockholder meeting or the first anniversary of the grant date, contingent on her continuous service. Any unexercised portion expires on May 19, 2036. This is an equity award, not an open-market stock purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Molineaux Susan
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 220,000 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 220,000 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Option grant size 220,000 options Stock Option (right to buy) granted to director
Exercise price $1.26 per share Conversion or exercise price of option grant
Underlying shares 220,000 shares Common stock underlying the option
Expiration date May 19, 2036 Option expiration for director grant
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price set at 1.2600 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"This option will vest and become exercisable as to 100% of the shares"
expiration date financial
"expiration_date listed as 2036-05-19 for the option"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Molineaux Susan
(Last)(First)(Middle)
C/O GERON CORPORATION
919 EAST HILLSDALE BOULEVARD, SUITE 250
(Street)
FOSTER CITY CALIFORNIA 94404
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GERON CORP [ GERN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$1.2605/20/2026A220,000 (1)05/19/2036Common Stock220,000$0220,000D
Explanation of Responses:
1. This option will vest and become exercisable as to 100% of the shares of common stock subject to such option on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders or (ii) the first anniversary of the date of grant of such option, subject to the Reporting Person's continuous service with the Issuer through such dates.
/s/Michelle Robertson, Attorney-in-Fact05/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Geron (GERN) director Susan Molineaux report in this Form 4?

She reported receiving a grant of stock options for 220,000 Geron common shares at a $1.26 exercise price. The award is a compensation grant, not an open-market transaction, and will vest in full subject to her continued service.

How many Geron (GERN) shares are covered by Susan Molineaux’s option grant?

The option grant covers 220,000 shares of Geron common stock. These shares become exercisable only after the option vests and are subject to an exercise price of $1.26 per share until the option’s stated expiration date.

What is the exercise price of Susan Molineaux’s Geron (GERN) stock options?

The exercise price is $1.26 per share for the 220,000 stock options. This means she can purchase Geron common shares at $1.26 once the option has vested, any time before the stated expiration date, if she chooses to exercise.

When do Susan Molineaux’s Geron (GERN) options vest?

The options vest and become fully exercisable on the earlier of the next Geron annual stockholder meeting or the first anniversary of the grant date. Vesting is conditioned on her maintaining continuous service with Geron through the applicable vesting date.

When do the Geron (GERN) stock options granted to Susan Molineaux expire?

The options expire on May 19, 2036, if not exercised earlier. After that expiration date, any unexercised portion of the 220,000-share option grant will lapse, and she will no longer have the right to buy shares under this award.